These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37350404)

  • 1. Procedure, management, and outcome of subcutaneous implantable cardioverter-defibrillator extraction in clinical practice.
    De Filippo P; Migliore F; Palmisano P; Nigro G; Ziacchi M; Rordorf R; Pieragnoli P; Di Grazia A; Ottaviano L; Francia P; Pisanò E; Tola G; Giammaria M; D'Onofrio A; Botto GL; Zucchelli G; Ferrari P; Lovecchio M; Valsecchi S; Viani S
    Europace; 2023 Jun; 25(6):. PubMed ID: 37350404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peri-procedural routines, implantation techniques, and procedure-related complications in patients undergoing implantation of subcutaneous or transvenous automatic cardioverter-defibrillators: results of the European Snapshot Survey on S-ICD Implantation (ESSS-SICDI).
    Lenarczyk R; Boveda S; Haugaa KH; Potpara TS; Syska P; Jedrzejczyk-Patej E; Chauvin M; Sadoul N; Dagres N
    Europace; 2018 Jul; 20(7):1218-1224. PubMed ID: 29762683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous Implantable Cardioverter-Defibrillator Lead Extraction: First Multicenter French Experience.
    Behar N; Galand V; Martins RP; Jacon P; Badenco N; Blangy H; Alonso C; Guy-Moyat B; El Bouazzaoui R; Lebon A; Giraudeau C; Marquie C; Leclercq C
    JACC Clin Electrophysiol; 2020 Jul; 6(7):863-870. PubMed ID: 32703570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead Abandonment and Subcutaneous Implantable Cardioverter-Defibrillator (S-ICD) Implantation in a Cohort of Patients With ICD Lead Malfunction.
    Russo V; Viani S; Migliore F; Nigro G; Biffi M; Tola G; Bisignani G; Dello Russo A; Sartori P; Rordorf R; Ottaviano L; Perego GB; Checchi L; Segreti L; Bertaglia E; Lovecchio M; Valsecchi S; Bongiorni MG
    Front Cardiovasc Med; 2021; 8():692943. PubMed ID: 34395560
    [No Abstract]   [Full Text] [Related]  

  • 5. Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation.
    Viani S; Migliore F; Tola G; Pisanò ECL; Russo AD; Luzzi G; Sartori P; Piro A; Rordorf R; Forleo GB; Rago A; Segreti L; Bertaglia E; Biffi M; Lovecchio M; Valsecchi S; Diemberger I; Bongiorni MG
    Heart Rhythm; 2019 Apr; 16(4):564-571. PubMed ID: 30366163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance and outcome of the subcutaneous implantable cardioverter-defibrillator after transvenous lead extraction.
    Chung DU; Tauber J; Kaiser L; Schlichting A; Pecha S; Sinning C; Rexha E; Reichenspurner H; Willems S; Gosau N; Hakmi S
    Pacing Clin Electrophysiol; 2021 Feb; 44(2):247-257. PubMed ID: 33377195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.
    Brunner MP; Cronin EM; Jacob J; Duarte VE; Tarakji KG; Martin DO; Callahan T; Borek PP; Cantillon DJ; Niebauer MJ; Saliba WI; Kanj M; Wazni O; Baranowski B; Wilkoff BL
    Heart Rhythm; 2013 Oct; 10(10):1444-50. PubMed ID: 23816440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry.
    Biffi M; Ammendola E; Menardi E; Parisi Q; Narducci ML; De Filippo P; Manzo M; Stabile G; Potenza DR; Zanon F; Quartieri F; Rillo M; Saporito D; Zacà V; Berisso MZ; Bertini M; Tumietto F; Malacrida M; Diemberger I
    Europace; 2019 Oct; 21(10):1527-1536. PubMed ID: 31209482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-incision technique for implantation of the subcutaneous implantable cardioverter-defibrillator.
    Knops RE; Olde Nordkamp LR; de Groot JR; Wilde AA
    Heart Rhythm; 2013 Aug; 10(8):1240-3. PubMed ID: 23707489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern subcutaneous implantable defibrillator therapy in patients with cardiomyopathies and channelopathies: data from a large multicentre registry.
    Migliore F; Biffi M; Viani S; Pittorru R; Francia P; Pieragnoli P; De Filippo P; Bisignani G; Nigro G; Dello Russo A; Pisanò E; Palmisano P; Rapacciuolo A; Silvetti MS; Lavalle C; Curcio A; Rordorf R; Lovecchio M; Valsecchi S; D'Onofrio A; Botto GL
    Europace; 2023 Aug; 25(9):. PubMed ID: 37536671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Appropriate Shocks and Antitachycardia Pacing in Transvenous and Subcutaneous Implantable Defibrillators: Analysis of All Appropriate Therapy in the PRAETORIAN Trial.
    Knops RE; van der Stuijt W; Delnoy PPHM; Boersma LVA; Kuschyk J; El-Chami MF; Bonnemeier H; Behr ER; Brouwer TF; Kääb S; Mittal S; Quast ABE; Smeding L; Tijssen JGP; Bijsterveld NR; Richter S; Brouwer MA; de Groot JR; Kooiman KM; Lambiase PD; Neuzil P; Vernooy K; Alings M; Betts TR; Bracke FALE; Burke MC; de Jong JSSG; Wright DJ; Jansen WPJ; Whinnet ZI; Nordbeck P; Knaut M; Philbert BT; van Opstal JM; Chicos AB; Allaart CP; Borger van der Burg AE; Clancy JF; Dizon JM; Miller MA; Nemirovsky D; Surber R; Upadhyay GA; Weiss R; de Weger A; Wilde AAM; Olde Nordkamp LRA;
    Circulation; 2022 Feb; 145(5):321-329. PubMed ID: 34779221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of hospital admission, need of on-demand analgesia and other peri-procedural and short-term outcomes in sub-cutaneous vs. transvenous implantable cardioverter-defibrillators.
    Boveda S; Chalbia TE; Jacob S; Combes S; Combes N; Cardin C; Laborie G; Sousa MJ; Jebberi Z; Mzoughi S; Albenque JP; Providencia R
    Int J Cardiol; 2018 May; 258():133-137. PubMed ID: 29544919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies.
    Basu-Ray I; Liu J; Jia X; Gold M; Ellenbogen K; DiNicolantonio J; Komócsi A; Vorobcsuk A; Kim J; Afshar H; Lam W; Mathuria N; Razavi M; Rasekh A; Saeed M
    JACC Clin Electrophysiol; 2017 Dec; 3(13):1475-1483. PubMed ID: 29759827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postapproval Study of a Subcutaneous Implantable Cardioverter-Defibrillator System.
    Gold MR; El-Chami MF; Burke MC; Upadhyay GA; Niebauer MJ; Prutkin JM; Herre JM; Kutalek S; Dinerman JL; Knight BP; Leigh J; Lucas L; Carter N; Brisben AJ; Aasbo JD; Weiss R;
    J Am Coll Cardiol; 2023 Aug; 82(5):383-397. PubMed ID: 37495274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.
    Russo V; Caturano A; Guerra F; Migliore F; Mascia G; Rossi A; Nesti M; Santobuono VE; Attena E; Tola G; Sciarra L; Conte G; Paoletti Perini A; Francia P; Dendramis G; Palamà Z; Albani S; Ottonelli Ghidini A; Calò L; D'Onofrio A; Baldi E;
    Heart Vessels; 2023 May; 38(5):680-688. PubMed ID: 36418560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and impact on patient outcome and healthcare utilization of complications requiring surgical revision: Subcutaneous versus transvenous implantable defibrillator therapy.
    Palmisano P; Ziacchi M; Ammendola E; D'Onofrio A; Dell'Era G; Laffi M; Biffi M; Nigro G; Bianchi W; Prenna E; Angeletti A; Guido A; Stronati G; Gaggioli G; Dello Russo A; Accogli M; Guerra F;
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1712-1723. PubMed ID: 33969569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
    Botto GL; Forleo GB; Capucci A; Solimene F; Vado A; Bertero G; Palmisano P; Pisanò E; Rapacciuolo A; Infusino T; Vicentini A; Viscusi M; Ferrari P; Talarico A; Russo G; Boriani G; Padeletti L; Lovecchio M; Valsecchi S; D'Onofrio A;
    Europace; 2017 Nov; 19(11):1826-1832. PubMed ID: 28011803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transvenous extraction of advisory implantable cardioverter defibrillator leads with a relatively long implant duration.
    Goya M; Nagashima M; Hiroshima KI; Hayashi K; Makihara Y; Fukunaga M; An Y; Ohe M; Sasaki T; Shiohira S; Shirai Y; Kawabata M; Ando K; Isobe M; Hirao K
    J Cardiol; 2018 Oct; 72(4):316-320. PubMed ID: 29705082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term complications in patients implanted with subcutaneous implantable cardioverter-defibrillators: Real-world data from the extended ELISIR experience.
    Gasperetti A; Schiavone M; Ziacchi M; Vogler J; Breitenstein A; Laredo M; Palmisano P; Ricciardi D; Mitacchione G; Compagnucci P; Bisignani A; Angeletti A; Casella M; Picarelli F; Fink T; Kaiser L; Hakmi S; Calò L; Pignalberi C; Santini L; Lavalle C; Pisanò E; Olivotto I; Tondo C; Curnis A; Dello Russo A; Badenco N; Steffel J; Love CJ; Tilz R; Forleo G; Biffi M
    Heart Rhythm; 2021 Dec; 18(12):2050-2058. PubMed ID: 34271173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanical extraction of implantable cardioverter-defibrillator leads with a dwell time of more than 10 years: insights from a single high-volume centre.
    Ząbek A; Boczar K; Ulman M; Holcman K; Kostkiewicz M; Pfitzner R; Dębski M; Musiał R; Lelakowski J; Małecka B
    Europace; 2023 Mar; 25(3):1100-1109. PubMed ID: 36660771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.